Buy Sanofi, target price Rs 7,170: Dharmesh Shah
Dharmesh Shah recommended to keep stoploss at Rs 6650.

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 15695.48 Crore) operating in Pharmaceuticals sector.
Sanofi India Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 2594.00 Crore to Sales Value (93.70 % of Total Sales), Sale of services which contributed Rs 145.70 Crore to Sales Value (5.26 % of Total Sales), Export Incentives which contributed Rs 26.60 Crore to Sales Value (0.96 % of Total Sales), Scrap which contributed Rs 1.40 Crore to Sales Value (0.05 % of Total Sales) and Other Operating Revenue which contributed Rs .60 Crore to Sales Value (0.02 % of Total Sales)for the year ending 31-Dec-2018.
For the quarter ended 30-09-2019, the company has reported a Standalone sales of Rs 779.10 Crore, up 4.17 % from last quarter Sales of Rs 747.90 Crore and up 11.20 % from last year same quarter Sales of Rs 700.60 Crore Company has reported net profit after tax of Rs 126.60 Crore in latest quarter. The company’s top management includes Dr.Shailesh Ayyangar, Mr.Aditya Narayan, Mr.Charles Billard, Mr.Cherian Mathew, Mr.Cyril Grandchamp Desraux, Mr.Rajaram Narayanan, Mr.Rangaswamy R Iyer, Mr.Thomas Rouckout, Ms.Usha Thorat. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditoRs As on 30-09-2019, the company has a total of 23,030,622 shares outstanding.
Download ET Markets APP